MAPT and Alzheimer disease: Others have also reported that transcripts from certain retrotransposons correlate with tau pathology (a key feature of Alzheimer's disease) (Guo et al., 2018), that inhibiting tau‐induced TEs with 3TC can protect against neurodegeneration in model organisms (Sun et al., 2018), and that tau may accelerate age‐related TE dysregulation in the mouse brain (Ramirez et al., 2022).